Physiotherapeutic correction of arterial stiffness at the comorbidity of arterial hypertension and hyperuricemia
Abstract
Hyperuricaemia is included in the risk factors for arterial hypertension. Arterial stiffness is one of the risk factors for arterial hypertension. The purpose of the study: to evaluate the effectiveness of low level laser therapy for the correction of hyperuricaemia and stiffness of the arterial wall at the comorbidity of hyperuricaemia with arterial hypertension. The study included 92 patients: 1st group — 42 patients with arterial hypertension, 2nd group — 50 patients with arterial hypertension in combination with hyperuricaemia. The low level laser therapy was performed by the Mustang 2000 apparatus with a wavelength of 635 nm. Correlation relationship between the level of uric acid and pulse wave velocity. After low level laser therapy, the level of uric acid decreased in the 1st group by 3.4 %, in the 2nd — by 19.1 %. In the 2nd group, the decrease in uric acid after low level laser therapy was 15.7 % more intense than in the 1st group. After low level laser therapy there was a pulse wave velocity decrease in both groups.
Thus, the effectiveness of low level laser therapy for the correction of arterial hypertension and the reduction of arterial wall stiffness with arterial hypertension comorbidity with hyperuricaemia are proved.
Downloads
References
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et. al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. Available from: https://academic.oup.com/eurheartj/article/39/33/3021/5079119 doi: 10.1093/eurheartj/ehy339.
Redon P, Maloberti A, Facchetti R, Redon J, Lurbe E, Bombelli M, et. al. Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the blood pressure control rate and cardiovascular risk profile study. J Hypertens. 2019 Feb;37(2):380-388. Available from: https://insights.ovid.com/pubmed?pmid=30074564 doi: 10.1097/HJH.0000000000001908.
Ofori SN, Odia OJ. Serum uric acid and target organ damage in essential hypertension. Vasc Health Risk Manag. 2014 May 2;10:253-61. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014451/ doi:10.2147/VHRM.S61363
Scheepers LEJM, Boonen A, Dagnelie PC, Schram MT, van der Kallen CJH, Henry RMA et. al. Uric acid and blood pressure: exploring the role of uric acid pro- duction in The Maastricht Study J Hypertens. 2017 Oct;35(10):1968-1975. Available from: https://insights.ovid.com/pubmed?pmid=28520613 doi: 10.1097/ HJH.0000000000001417
Kuwabara M. Hyperuricemia, Cardiovascular Disease, and Hypertension. Pulse (Basel). 2016;3(3-4):242-52. Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4865070/ doi: 10.1159/000443769
Ramirez, A. J., Christen, A. I., & Sanchez, R. A. (2018). Serum Uric Acid Elevation Is Associated To Arterial Stiffness In Hypertensive Patients With Metabolic Disturbances. Curr Hypertens Rev. 2018;14(2):154-160. Available from: http://www.eurekaselect.com/161262/ article doi: 10.2174/1573402114666180413143312.
Gunawardhana L, McLean L, Punzi HA, Hunt B, Palmer RN, Whelton A et al. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study. J Am Heart Assoc. 2017 Nov 4;6(11). pii: e006683. Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC5721765/ doi: 10.1161/JAHA.117.006683.
Kovalenko YL, Rudenko LA, Melekhovets OK, Chepeliuk AD, Melekhovets IV Efficiency of hyperuricemia correction by low level laser therapy in the treatment of arterial hypertensionWiad Lek. 2018;71(7):1310-1315.
Наказ МОЗ України від 24.05.2012 № 384 «Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при артеріальній гіпертензії» Доступно: http://old.moz. gov.ua/ua/portal/dn_20120524_384.html
Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C et al. Acute systemic inflam- mation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005 Oct 4;112(14):2193-200. Available from: https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONA- HA.105.535435
Tomiyama H, Shiina K , Vlachopoulos C , Iwasaki Y , Matsumoto C , Kimura K et al. Involvement of Arterial Stiffness and Inflammation in Hyperuricemia-Related Development of Hypertension Hypertension. 2018 Sep; 72(3):739-745. Available from: https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.118.11390 doi: 10.1161/HYPERTENSIONAHA.118.11390
Yokokawa H, Fukuda H, Suzuki A, Fujibayashi K, Naito T et. al. Association Between Serum Uric Acid Levels/ Hyperuricemia and Hypertension Among 85,286 Jap- anese Workers. J Clin Hypertens (Greenwich). 2016 Jan;18(1):53-9. Available from: https://onlinelibrary. wiley.com/doi/full/10.1111/jch.12627 doi: 10.1111/ jch.12627. Epub 2015 Jul 25.
